Drug Pipeline

QCZ484 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-02	NCT06857955 A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients	overall status: "Recruiting" → "Active Not Recruiting"
2026-06-02	NCT06857955 A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients	Trial sites reduced: 84 -> 81 locations
2026-06-02	NCT07543120 An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.	Recruitment opened
2026-06-02	NCT07543120 An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.	Trial sites expanded: 0 -> 7 locations

New Trial Filings, Last 30 Days

First Posted	Trial	Phase	Status
2026-05-27	NCT07610278 A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in…	Phase 2	Not Yet Recruiting

Active Studies by Phase

Phase 2

Active Trials

NCT ID	Title	Condition	Status
Phase 2
NCT07543120	An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.	Hypertension (HTN)	Recruiting
NCT07610278	A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in…	Hypercholesterolaemia	Not Yet Recruiting
NCT06857955	A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients	Hypertension	Active, Not Recruiting

Sponsors Running QCZ484 Trials

Novartis Pharmaceuticals (3)

Disease Areas

Hypertension (2)

Get alerts when QCZ484 trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.